Results 131 to 140 of about 4,657,009 (154)

Direct oral anticoagulant rivaroxaban for secondary prevention of catheter-related thrombosis in children with intestinal failure: real-life data. [PDF]

Res Pract Thromb Haemost
Hilberath J, Ballauff A, Rückel A, Sieverding L, Vermeulen D, Eberl W, Hartleif S, Lieber J, Michel J, Sturm E, Nordmeyer J, Icheva V.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes

Thrombosis Research, 2023
Shengfeng Wang, Minghua Yang
exaly  

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples

Research and Practice in Thrombosis and Haemostasis, 2022
Pieter M De Kesel, Katrien Devreese
exaly  

Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation

Journal of Cardiovascular Pharmacology and Therapeutics, 2021
Bruria Hirsh-Raccah, Mordechai Muszkat
exaly  

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study

Gastroenterology, 2017
Xiaoxi Yao, Neena S Abraham
exaly  

Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis

Journal of the American Heart Association, 2018
Ulf Ziemann, Sven Poli
exaly